Denker, Andrew Evan,Kato, Yu,Tabata, Kimiyo,Hori, Yusaku
申请号:
AU2015384801
公开号:
AU2015384801A1
申请日:
2015.12.03
申请国别(地区):
AU
年份:
2017
代理人:
摘要:
The present disclosure describes combination therapies comprising an antagonist of Programmed Death 1 receptor (PD-1) and a multi-RTK inhibitor, and the use of the combination therapies for the treatment of cancer. The multi-RTK inhibitor may be represented by Formula (I): wherein R